Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Salomon Manier

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
Leukemia|November 14, 2019
On the road to molecular prognostication in SMMSalomon Manier
Bulletin Du Cancer|December 18, 2021
[Bispecific antibodies in multiple myeloma]Guillaume Escure, Salomon Manier
Blood|January 24, 2023
How I treat multiple myeloma in geriatric patientsThierry Facon, Xavier Leleu, Salomon Manier
Medecine Sciences : M/S|December 5, 2017
[Circulating exosomal microRNA as biomarkers in mutiple myeloma]Salomon Manier, Xavier Leleu, Hervé Avet-Loiseau
American Journal of Hematology|April 13, 2026
Circulating Tumor Cells in Multiple Myeloma: From Peripheral Clues to Central InsightsBenjamin Podvin, Bruno Paiva, Irene M Ghobrial, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Future Directions in the Evaluation and Treatment of Precursor Plasma Cell DisordersSalomon Manier, Karma Z Salem, David Liu, et al.
American Journal of Hematology|January 26, 2019
Antigen excess pitfall for free light chains measurements solved by ELISA assayJean-David Pekar, Susanna Schraen, Guillaume Grzych, et al.
The Lancet. Oncology|February 5, 2026
Daratumumab-lenalidomide and the immunosuppressive budget in myeloma - Authors' replySalomon Manier, Jérôme Lambert, Cyrille Hulin, et al.
Current Opinion in Hematology|April 22, 2016
Cell autonomous and microenvironmental regulation of tumor progression in precursor states of multiple myelomaSalomon Manier, Yawara Kawano, Giada Bianchi, et al.
Cancer Treatment and Research|October 4, 2016
Genomic Aberrations in Multiple MyelomaSalomon Manier, Karma Salem, Siobhan V Glavey, et al.
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
Leukemia|November 14, 2019
On the road to molecular prognostication in SMMSalomon Manier
Bulletin Du Cancer|December 18, 2021
[Bispecific antibodies in multiple myeloma]Guillaume Escure, Salomon Manier
Blood|January 24, 2023
How I treat multiple myeloma in geriatric patientsThierry Facon, Xavier Leleu, Salomon Manier
Medecine Sciences : M/S|December 5, 2017
[Circulating exosomal microRNA as biomarkers in mutiple myeloma]Salomon Manier, Xavier Leleu, Hervé Avet-Loiseau
American Journal of Hematology|April 13, 2026
Circulating Tumor Cells in Multiple Myeloma: From Peripheral Clues to Central InsightsBenjamin Podvin, Bruno Paiva, Irene M Ghobrial, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Future Directions in the Evaluation and Treatment of Precursor Plasma Cell DisordersSalomon Manier, Karma Z Salem, David Liu, et al.
American Journal of Hematology|January 26, 2019
Antigen excess pitfall for free light chains measurements solved by ELISA assayJean-David Pekar, Susanna Schraen, Guillaume Grzych, et al.
The Lancet. Oncology|February 5, 2026
Daratumumab-lenalidomide and the immunosuppressive budget in myeloma - Authors' replySalomon Manier, Jérôme Lambert, Cyrille Hulin, et al.
Current Opinion in Hematology|April 22, 2016
Cell autonomous and microenvironmental regulation of tumor progression in precursor states of multiple myelomaSalomon Manier, Yawara Kawano, Giada Bianchi, et al.
Cancer Treatment and Research|October 4, 2016
Genomic Aberrations in Multiple MyelomaSalomon Manier, Karma Salem, Siobhan V Glavey, et al.
Pageof 16